Interleukin-15 Compositions And Uses Thereof

Abstract

Interleukin-15 muteins and other interleukin-15-related molecules are described, as well as methods of identifying interleukin-15 muteins and other interleukin-15-related molecules. Also described herein are modifications of the foregoing, which modifications may enhance a property (e.g., half-life) of the muteins or other molecules compared to human interleukin-15. Pharmaceutical compositions and methods of use are also described herein.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2019
  • Application: Oct 12, 2015
    US US 201515513820 A
  • Priority: Oct 12, 2015
    US US 201515513820 A
  • Priority: Oct 12, 2015
    US US 2015/0055156 W
  • Priority: Oct 14, 2014
    US US 201462063784 P

Download Citation


Sign in to the Lens

Feedback